Evidence map›Paper›PMID 25505555›Full record

ArticlePharmacology research & perspectives2013

α1D-Adrenoceptors are responsible for the high sensitivity and the slow time-course of noradrenaline-mediated contraction in conductance arteries.

Nicla Flacco, Jaime Parés, Eva Serna, Vanessa Segura, Diana Vicente, Miguel Pérez-Aso, María Antonia Noguera, María Dolores Ivorra, John C McGrath, Pilar D'Ocon

Open access · goldAbstract read
In one paragraph

Article in Pharmacology research & perspectives, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Updates in the function and regulation of αBritish journal of pharmacology · 2019
    Review
  3. Activation of αBritish journal of pharmacology · 2017
    Article
  4. Localization of α-adrenoceptors: JR Vane Medal Lecture.British journal of pharmacology · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Nicla FlaccoDepartamento de Farmacología, Facultad de Farmacia, Universitat de València Valencia, Spain.
Jaime ParésDepartamento de Farmacología, Facultad de Farmacia, Universitat de València Valencia, Spain.
Eva SernaDepartamento de Farmacología, Facultad de Farmacia, Universitat de València Valencia, Spain.
Vanessa SeguraDepartamento de Farmacología, Facultad de Farmacia, Universitat de València Valencia, Spain.
Diana VicenteDepartamento de Farmacología, Facultad de Farmacia, Universitat de València Valencia, Spain.
Miguel Pérez-AsoDepartamento de Farmacología, Facultad de Farmacia, Universitat de València Valencia, Spain.
María Antonia NogueraDepartamento de Farmacología, Facultad de Farmacia, Universitat de València Valencia, Spain.
María Dolores IvorraDepartamento de Farmacología, Facultad de Farmacia, Universitat de València Valencia, Spain.
John C McGrathAutonomic Physiology Unit, School of Life Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow Glasgow, U.K.
Pilar D'OconDepartamento de Farmacología, Facultad de Farmacia, Universitat de València Valencia, Spain.
Universitat de València · ESUniversity of Glasgow · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The objective of this study was to determine whether the different time-course characteristics of α1-adrenoceptor-mediated contraction in arteries can be related to the subtypes involved. Contractile responses to noradrenaline (NA) were compared with inositol phosphate accumulation and extracellular signal-regulated kinase (ERK)1/2 phosphorylation after α1-agonist stimuli in the same vessels in the presence or absence of α1-antagonists in rat or in α1-subtype knockout (KO) mice. Aorta, where α1D-AR is the main functional subtype, had higher sensitivity to NA (in respect of inositol phosphate [IP], pERK1/2, and contractile response) than tail artery, where the α1A-adrenoceptor subtype is predominant. Furthermore, the contraction in aorta exhibited a slower decay after agonist removal and this was consistent in all strains harboring α1D-adrenoceptors (from rat, α1B-KO, and wild-type [WT] mice) but was not observed in the absence of the α1D-adrenoceptor signal (α1D-adrenoceptor blocked rat aorta or aorta from α1D-KO). IP formation paralleled α1-adrenoceptor-mediated contraction (agonist present or postagonist) in aorta and tail artery. High sensitivity to agonist and persistence of response after agonist removal is a property of α1D-adrenoceptors. Therefore, the preponderance of this subtype in noninnervated conductance arteries such as aorta allows responsiveness to circulating catecholamines and prevents abrupt changes in vessel caliber when the stimulus fluctuates. Conversely, in innervated distributing arteries, high local concentrations of NA are required to activate α1A-adrenoceptors for a response that is rapid but short lived allowing fine adjustment of the contractile tone by perivascular sympathetic nerves.

Indexed as

conductance and resistance vesselscontraction time-courseα1A-adrenoceptors

Identifiers

PMID25505555
PMCPMC4184566
OpenAlexW2033337889

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.